Publications

5808 Results

Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic medical center

Authors
EM Grainger;HS Kim;JP Monk;SA Lemeshow;M Gong;RR Bahnson;SK Clinton
Journal / Conference
Urologic Oncology 26(2):125-132
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID18312929
Study Number(s)
SWOG-9217

Correlation of kinase genotype and clinical outcome in the North American Intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by Cancer and Leukemia Group B and Southwest Oncology Group [PMC2651078; PMID18955451]

Authors
MC Heinrich;K Owzar;CL Corless;D Holllis;EC Borden;CD Fletcher;CW Ryan;M von Mehren;CD Blanke;C Rankin;RS Benjamin;VH Bramwell;GD Demetri;MM Bertagnolli;JA Fletcher
Journal / Conference
Journal of Clinical Oncology 26(33):5360-5357
Year
2008
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, decarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and decarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group [PMC2645104; PMID 19001327]

Authors
MB Atkins;J Hsu;S Lee;GI Cohen;LE Flaherty;JA Sosman;VK Sondak;JM Kirkwood
Journal / Conference
Journal of Clinical Oncology 26(35):5748-5754
Year
2008
Research Committee(s)
Melanoma
Study Number(s)
E3695

Analytical approaches for the BOAC SNP panel association with progression free survival in myeloma

Authors
B Van Ness;C Ramos;VK Kumar;M Steinbach;B Durie;J Crowley;B Barlogie;A Hoering;J Haessler;DC Johnson;G Morgan
Journal / Conference
Blood 112:abst.#2715
Year
2008
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

A phase II second-line study of pemetrexed (pem) in combination with bevacizumab (bev) in patients with advanced non-small cell lung cancer (NSCLC): an NCCTG and SWOG study

Authors
AA Adjei;SJ Mandrekar;GK Dy;JR Molina;DR Gandara;KL Ziegler;PJ Stella;KM Rowland;SR Schild;RG Zinner
Journal / Conference
Journal of Clinical Oncology 26(15s):abst. #8080
Year
2008
Research Committee(s)
Lung
Study Number(s)
N0426

Older adolescents and young adults with acute lymphoblastic leukemia (ALL) in the United States: from the lowest to highest death rate and number of deaths -- more rationale for the CALBG-WSOG-ECOG C10403 trial based on COG AALL0232

Authors
WA Bleyer
Journal / Conference
Journal of Clinical Oncology 26(15s):abstr. #18034
Year
2008
Research Committee(s)
Leukemia
Study Number(s)
C10403

Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group study

Authors
LM Randall;BJ Monk;J Moon;R Parker;SP Wilczynski;JP Fruehauf;RA Burger
Journal / Conference
Gynecologic Oncology 108(3) Suppl. 1:S3
Year
2008
Research Committee(s)
Gynecologic
Study Number(s)
S0013

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100 [PMC2653128; PMID18824714]

Authors
BP Schneider;M Wang;M Radovich;GW Sledge;S Badve;A Thor;D Flockhart;B Hancock;N Davidson;J Gralow;M Dickler;EA Perez;H Cobleigh;T Shenkier;S Edgerton;KD Miller
Journal / Conference
Journal of Clinical Oncology 26(28):4672-4678
Year
2008
Research Committee(s)
Breast
Study Number(s)
CTSU/E2100

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherappy for carcinoma of the anal canal: a randomized controlled trial. [PMID18430910]

Authors
JA Ajani;KA Winter;LL Gunderson;J Pedersen;AB Benson;CR Thomas;RJ Mayer;MG Haddock;TA Rich;C Willett
Journal / Conference
Journal of the American Medical Association 299(16):1914-1921
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
R9811

Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741 [PMID19001325; PMC2645101]

Authors
HK Sanoff;DJ Sargent;ME Campbell;RF Morton;CS Fuchs;RK Ramanathan;SK Williamson;BP Findlay;HC Pitot;R Goldberg
Journal / Conference
Journal of Clinical Oncology 26(35):5721-5727
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
N9741